Registry for assessing treatments of benign prostatic hyperplasia
Official title: Database for the Assessment of Efficacy and Safety of BPH Treatment
Run by Cantonal Hospital of St. Gallen · NCT03521648 · Data updated 2026-11-12
This study is collecting information to see how well different treatments for enlarged prostate symptoms work, comparing new options with traditional ones for men aged 18 and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 500 (estimated) |
| Sponsor | Cantonal Hospital of St. Gallen Academic / other |
| Locations | 1 site (Sankt Gallen, Canton of St. Gallen) |
| Status | Recruiting |
| Started | July 7, 2017 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | January 26, 2021 |
| Trial ID | NCT03521648 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult patients aged 18 and older who are being treated for BPH or LUTS at the participating institution.
✕Probably not a fit
Patients with cognitive impairments that prevent them from providing informed consent or adequately assessing data will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data on the efficacy and safety of various treatments for benign prostatic enlargement (BPE) and lower urinary tract symptoms (BPH-LUTS). It includes clinical, patient-reported, and imaging data from patients treated at the urological department of St. Gallen Cantonal Hospital. The study aims to compare novel treatment options, such as prostatic artery embolization, with established interventions like TURP and laser therapies. Participation requires informed consent from patients aged 18 and older.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the most effective treatments for benign prostatic hyperplasia, improving patient outcomes.
How similar studies have gone: Other studies have successfully assessed treatment efficacy for BPH, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG * Patient age ≥ 18 years * Informed consent provided Exclusion Criteria: -Cognitive impairment not allowing Informed Consent or adequate data assessment.
Where it's running
-
St. Gallen Cantonal Hospital
Sankt Gallen, Canton of St. Gallen, Switzerland Recruiting
Study contacts
- Study coordinator: Dominik Abt, MD
- Email: dominik.abt@kssg.ch
- Phone: +41 71 494 14 16
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate
This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.
-
Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia
This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.
-
Water Vapor Therapy versus Ejaculation-Preserving HoLEP for Benign Prostatic Hyperplasia
This study compares Rezum water vapor therapy to ejaculation-preserving HoLEP in sexually active men with moderate-to-severe symptoms from BPH to see which preserves ejaculation better while easing urinary symptoms.
-
Ejaculation-Preserving Bipolar Prostate Enucleation for BPH
This randomized trial tests whether a modified ejaculation-preserving bipolar TUEP can maintain ejaculation while still relieving urinary symptoms in sexually active men with BPH who didn’t improve with meds.
-
Global registry for benign prostatic hyperplasia treatments
This study is collecting information from men with benign prostatic hyperplasia to see how different treatments work and to help improve future care.
-
Sonablate HIFU Registry for Prostate Cancer and BPH
This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.